What Ashland does

Ashland Inc. is a global specialty chemicals and specialty ingredients company founded in 1924 and publicly traded on the NYSE under the ticker ASH, with its corporate headquarters in Wilmington, Delaware, and approximately 4,200 employees serving customers in more than 100 countries. The company operates through four primary business units—Personal Care, Life Sciences, Specialty Additives, and Intermediates—plus Performance Specialties and Crop Care, supplying formulation-critical ingredients such as pharmaceutical excipients (Viatel™ bioresorbable polymers, Klucel™), personal care biofunctionals (Vincience™ portfolio including Perfectyl™, Infini'tea™, Harmoniance™, and the recently launched Eternight™), coatings additives, food and beverage ingredients, agrimer eco-coat polymer seed coatings, and Gafchromic™ medical dosimetry films. Ashland's competitive positioning is anchored by proprietary extraction and processing technologies—PSR™ (Plant Small RNA) for small-RNA-rich plant extracts, Zeta Fraction™ for solvent-free separation of bioactive components using mobile processing units, and Transformed Vegetable Oils (TVO) for seed coatings—plus a portfolio of formulation platforms spanning super wetting agents, novel cellulosics, liquid cellulose+, multifunctional starches, and pH neutralizers.

Ashland generates revenue primarily through direct B2B sales of its specialty ingredients and additives via field sales teams serving enterprise customers across pharmaceutical, personal care, coatings, food and beverage, automotive, construction, energy, and agricultural end markets. Pricing is quote-based and contracts are typically multi-year; the company also operates the iSolve customer portal and a suite of digital selector tools that support product discovery and sample requests. Geographically, Ashland maintains manufacturing in the U.S. (including the Hopewell, Virginia plant currently experiencing productivity challenges), Ireland (Mullinger injectables facility, recently expanded for the second time), Brazil (Cabreúva pharmaceutical plant), and commercial/R&D presence across North America, EMEA, APAC (China, India, Australia, Japan, Singapore, South Korea), and Latin America.

Recent performance reflects a multi-year revenue contraction from approximately $2.39B in FY2022 to roughly $1.82B in FY2025, driven by portfolio divestitures (notably the adhesives business sold to Arkema) and operational headwinds; FY2026 guidance of $1.835-$1.870B is essentially flat with the prior year, while Q2 FY2026 adjusted EBITDA declined 9% year-over-year to $98M. The company faces activist investor pressure from Ancora Alternatives and Cruiser Capital advocating for a sale (Ancora estimates a $76/share takeout), an S&P credit downgrade from BB+ to BB in February 2026, and a securities fraud investigation following the Q2 2026 earnings miss. Offsetting these pressures are continued dividend growth (16 consecutive years of increases, 2.9% yield), regulatory wins (EPA FIFRA approval for Agrimer Eco-coat in February 2026), and the launch of premium biofunctional innovation platforms that have surpassed internal revenue targets.

Name

Ashland

Legal name

Ashland Inc.

Website

https://ashland.com

Company type

Public

Founded year

1924

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Ashland Inc. is a global specialty chemicals and specialty ingredients company that supplies pharmaceutical excipients, personal care biofunctionals, coatings additives, food and beverage ingredients, and crop care products to enterprise customers across more than 100 countries.

Ownership category

akta.pro rank

Product category

Specialty Chemicals

NAICS

Chemical Manufacturing (325), Paint and Coating Manufacturing (325510), Analytical Laboratory Instrument Manufacturing (334516), Custom Compounding of Purchased Resins (325991)

SIC

Miscellaneous Chemical Products (2890), Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)

akta.pro primary industry

Personal Care & Cosmetic Ingredients (IMAEABAJ)

akta.pro secondary industries

Medical & Food-Contact Specialty Compounds (IMANABAK), Food-Grade Additives & Functional Ingredients Trading/Wholesale (AFAIAKAI), Textile, Leather & Paper Specialty Chemicals (IMAEABAM)

Keywords

• Specialty chemicals
• Pharmaceutical excipients
• Personal care ingredients
• Biofunctional additives
• Industrial coatings chemicals

Headquarters

HQ city

Covington

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Specialty Chemicals and Ingredients: Ashland generates revenue through the manufacture and sale of specialty additives and ingredients to consumer and industrial markets including pharmaceuticals, personal care, automotive, construction, energy, food and beverage, and coatings. The company operates through business units: Life Sciences, Personal Care, Specialty Additives, and Intermediates.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Ashland manufactures and sells specialty additives and specialty ingredients across pharmaceutical, personal care, coatings, food and beverage, crop care, and industrial markets. The company's portfolio centers on biofunctional ingredients (Vincience™), pharmaceutical excipients and bioresorbable polymers (Viatel™), cellulosics, rheology modifiers, and crop protection chemistries, organized into Life Sciences, Personal Care, Specialty Additives, and Intermediates business units. Ashland also offers Gafchromic™ medical dosimetry films and supporting filmQA pro™ software for healthcare and research customers.

Product overview

Ashland is a specialty materials company offering additives and specialty ingredients across four business units: Personal Care and Household, Life Sciences, Specialty Additives, and Intermediates. The product portfolio centers on the Vincience™ biofunctional ingredients line featuring botanical extracts and active ingredients for skin, hair, and personal care, alongside pharmaceutical solutions including Viatel™ bioresorbable polymers for injectable drug delivery and Gafchromic™ medical dosimetry films. The company operates multiple technology platforms including Transformed Vegetable Oils (TVO), bioresorbable polymers, super wetting agents, liquid cellulose+, novel cellulosics, and multifunctional starch platforms. Key proprietary extraction technologies include the patented PSR™ (Plant Small RNA) technology and Zeta Fraction™ technology for processing live plants into bioactive ingredients. Customers access products through the iSolve customer portal which provides technical literature, formulations, regulatory documentation, and sample requests. Digital selector tools enable customers to filter products by chemistry, application, sustainability certifications, and performance criteria.

Differentiator

Problem solved

Functional benefit

Brands

• Vincience: Biofunctional ingredients portfolio for personal care, featuring plant-based cosmetic actives and proprietary extraction technologies including PSR and Zeta Fraction.
• Viatel
• Natrosol
• Agrimer eco-coat
• Eternight

Products and services

• Viatel™ bioresorbable polymers Platform of bioresorbable polymers used in parenteral controlled-release drug delivery and medical device formulations for pharmaceutical customers.
• Vincience™ biofunctional ingredients Skin, hair, and personal care biofunctional ingredients portfolio featuring plant-based cosmetic actives produced via proprietary PSR™ and Zeta Fraction™ extraction technologies.
• Agrimer Eco-coat polymer seed coating Polymer seed coating based on Transformed Vegetable Oils technology, EPA-approved under FIFRA for use in all food and non-food pesticide formulations for agricultural customers.
• Gafchromic™ dosimetry films Medical radiation measurement films used for high-dose dosimetry, research, radiology, radiotherapy, and blood safety applications by healthcare and research institutions.
• filmQA pro™ software Software for medical film dosimetry analysis and quality control used alongside Gafchromic dosimetry films in radiology and radiotherapy workflows.
• Perfectyl™ biofunctional High-tech chamomile extract biofunctional produced using Zeta Fraction™ technology and AI for anti-aging and anti-blemish skincare formulations.
• Infini'tea™ biofunctional Ultra-fresh tea serum extracted from live Camellia sinensis tea leaves using Zeta Fraction™ technology for neurocosmetic and balancing skincare applications.
• Harmoniance™ biofunctional Botanical biofunctional obtained from fresh Sacred Lotus (Nelumbo nucifera) using Zeta Fraction™ technology preserving original cellular architecture and capturing synergistic properties.
• Eternight™ biofunctional Mitochondria-inspired biofunctional ingredient for skin longevity supporting nocturnal skin recovery and cellular repair, derived from Iris pallida rhizome using PSR™ technology.
• Easywet substrate wetting agents Substrate wetting agents for specialty and industrial coatings providing optimal coverage and environmental safety for architectural and industrial coatings manufacturers.
• Klucel™ (hydroxypropylcellulose) Low-substituted hydroxypropylcellulose excipient for oral solid dose pharmaceutical applications.
• Stabileze™ polymer Polymer for skin and sun care applications providing stability and performance.
• Phyteq™ Raspberry Plus Multifunctional biofunctional ingredient for skin and sun care applications.
• Vital ET™ SP biofunctional Biofunctional ingredient that activates skin calming properties for personal care applications.
• Gantrez soja delivery system Soybean oil-derived biodegradable delivery system for advanced oral care products.

Quantifiable outcome

• Innovation platform 'Innovate' surpassed $15 million annual revenue target after just two quarters
• +2 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Schülke & Mayr GmbHminorOthers · 30 April 2021Ashland completed acquisition of personal care business from Schülke & Mayr GmbH (portfolio company of EQT) in April 2021.
• The Nature ConservancycoreStrategic or Co-development PartnerAshland supports The Nature Conservancy through funding STEM youth engagement programs, Nature Lab, and Plant a Billion Trees program. Partnership demonstrates commitment to environmental conservation and biodiversity.
• SM Sehgal FoundationcoreStrategic or Co-development PartnerPartnership for STEM education pilot program with small farmers in Sriganganagar district of Rajasthan, India. Educational programs and scientific solutions supporting sustainable guar farming and empowering local communities.
• Greenlight for GirlsminorStrategic or Co-development PartnerInternational non-profit dedicated to inspiring girls of all ages and backgrounds to pursue STEM subjects. Ashland donated $20,000 in 2022 to support programs introducing girls to science in fun and exciting ways.
• Delaware STEM Educators AwardsminorStrategic or Co-development PartnerAshland sponsors annual awards recognizing and supporting high school, middle school, and elementary school teachers for their work in STEM education. Eight years of sponsorship demonstrating commitment to STEM workforce development.

Scale indicators9 records

Recent moves9 records

Expansion highlights5 records

Broad incumbents

• DuPont: Diversified specialty materials company with electronics, water, healthcare, and industrial bioproducts. Comparable in life sciences/polymer specialties and broader industrial specialty additives where Ashland competes.
• BASF: World's largest chemical company with broad portfolios spanning personal care, pharma, coatings, crop science, and intermediates. Overlaps with Ashland in nearly every segment but as a much larger, diversified incumbent.

Direct peers

• Givaudan: World's largest fragrance and flavor company with a strong active beauty and biofunctional ingredients portfolio. Comparable premium positioning in personal care specialty ingredients and similar B2B enterprise sales model to consumer goods manufacturers.
• Symrise: German specialty chemicals company serving flavors, fragrances, nutrition, and cosmetic ingredients markets. Closely comparable in personal care bioactives and food ingredient segments, with overlapping B2B enterprise customer base.
• International Flavors & Fragrances (IFF): Global leader in flavors, fragrances, and food ingredients with a sizable specialty ingredients and biofunctional personal care business (Health & Biosciences). Most direct comparable in personal care specialty ingredients and food/beverade ingredient categories where Ashland competes.
• Croda International: UK-listed specialty chemicals company focused on sustainable, bio-based ingredients for personal care, life sciences, and industrial specialties. Highly comparable in personal care biofunctionals, pharmaceutical excipients, and ESG-led growth strategy.
• Sensient Technologies: Specialty ingredients producer for food and beverage, personal care, and pharmaceutical markets. Direct overlap with Ashland's natural colors/flavors and personal care specialty ingredients segments.
• Innospec: Specialty chemicals company serving fuel additives, oilfield, and personal care markets. Comparable in specialty formulation know-how and serving similar B2B enterprise customers across regulated end-markets.
• Stepan Company: Specialty and intermediate chemicals manufacturer serving personal care, pharmaceutical, and industrial customers. Comparable in surfactants, polymers, and specialty ingredients; similar B2B direct-sales model and middle-market scale.
• Lubrizol (Berkshire Hathaway): Specialty chemicals business owned by Berkshire Hathaway producing personal care, pharmaceutical, and industrial specialty ingredients. Closely comparable in pharmaceutical excipients, personal care rheology modifiers, and engineered polymers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeplayer.vimeo.com/video/941723348
• LinkedInlinkedin.com/company/ashland-inc
• Xx.com/AshlandInc
• Facebookfacebook.com/AshlandInc

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ashland